February 2018 FDA Recall Drug by Kalchem International, Inc.
D-0582-2018 - cGMP Deviations
This Class II drug recall was voluntarily initiated by Kalchem International, Inc. on February 19, 2018 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in TX and the recall is currently terminated.
Recall Number: D-0582-2018
cGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
02-19-2018
03-14-2018
500 gram jar
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Kalchem International, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
TX
09-15-2020
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Vardenafil HCl, USP (trihydrate), 500 GM Part # 330-05, Rx only, For Manufacturing, Repackaging and Processing for Rx and Research Only, Kalchem International, Inc. 224 South Main Street Lindsay, OK 73052 888-298-9905, NDC 60592-330-05
Batch or Lot Expiration Information
Lot# : 070717-1